Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells

Journal of Immunology

Volumn 163, Issue 7, 1999, Pages 3597-3604

  Ferlazzo, Guido ^a   Wesa, Amy ^a   Wei, Wei Zen ^a   Galy, Anne ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; MONOCYTE; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD34; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; HUMANS; LYMPHOCYTE ACTIVATION; MONOCYTES; OLIGOPEPTIDES; RECEPTOR, ERBB-2; STEM CELLS; TIME FACTORS;

EID: 0033214475     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Banchereau. J., and R. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Flamand, V., T. Sornasse, K. Thielemans, C. Demanet, M. Bakkus, H. Bazin, F. Tielemans, O. Leo, J. Urbain, and M. Moser. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:605.
3. Mayordomo, J., T. Zorina, W. Storkus, L. Zitvogel, C. Celluzzi, L. Falo, C. Melief, S. Ildstad, W. Kast, A. Deleo, et al. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1:1297.
4. Porgador, A., D. Snyder, and E. Gilboa. 1996. Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol. 156:2918.
5. Nestle, F., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328.
6. + hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res. 55:1099.
7. Romani, N., D. H. Reider, M., S. Ebner, E. Kampgen, B. Eibl, D. Niederwieser, and G. Schuler. 1996. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J. Immunol. Methods 196:137.
8. Galy, A., M. Travis, D. Cen, and B. Chen. 1995. Human T, B, natural killer and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3:459.
9. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFα. J. Exp. Med. 184:695.
10. + progenitor cells with flt3-ligand, c-kit-ligand, GM-CSF, IL-4 and TNF-α are functional antigen-presenting cells resembling mature monocyte-derived DC. J. Immunother. In press.?Author: Please update if possible.
11. + progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of Melan-A/MART-1 27-35-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors. Cancer Res. 57:5534.
12. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and down-regulated by tumor necrosis factor α. J. Exp. Med. 179:1109.
13. + T cells in vitro. Blood 91:4652.
14. Fisk, B., T. L. Blevins, J. T. Wharton, and C. G. loannides. 1995. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J. Exp. Med. 181:2109.
15. Lutsgarten, J., M. Theobald, C. Labadie, D. LaFace, P. Peterson, M. L. Disis, M. A. Cheever, and L. A. Sherman. 1997. Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2. 1 and human CD8. Hum. Immunol. 52:109.
16. + tumors. Cancer Res. 58:4902.
17. Kawashima, I., S. J. Hudson, V. Tsai, S. Southwood, K. Takesako, E. Appella, A. Sette, and E. Celis. 1998. The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors. Hum. Immunol. 59:1.
18. Schwarz, H., F. Blanco, J. von Kempis, J. Valbracht, and M. Lotz. 1996. ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood 87:2839.
19. Hollsberg, P., V. Batra, and D. A. Hafler. 1996. Induction of anergy in CD8 T cells by B cell presentation of antigen. J. Immunol. 157:5269.
20. Schwarz, H., J. Valbracht, J. Tuckwell, J. von Kemplis, and M. Lotz. 1995. IL-A, the human 4-1BB homologues, is inducible in lymphoid and other cell lineages. Blood 85:1043.
21. Galy, A., K. Georgopoulos, and L. Wu. 1999. Hematopoietic cell fate and the development of dendritic cells. In Dendritic Cells: Biology and Clinical Applications, A. W. Thompson, M. T. Lotze, eds. Academic Press, New York. In press.
22. + T cells. J. Immunol. 158:1551.
23. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kündig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell co-stimulation requirements in CD28-deficient mice. Science 261:609.
24. DeBenedette, M. A., A. Shahinian, T. W. Mak, and T. H. Watts. 1997. Costimulation of CD28-T lymphocytes by 4-1BB ligand. J. Immunol. 158:551.
25. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186:47.